Analysis Supports Role of Lotilaner Ophthalmic Solution for Demodex Blepharitis
HCP Live,
Credit: Unsplash/Perchek Industries A recent systematic review and meta-analysis evaluated the safety and efficacy of lotilaner…
Here’s the Eyelid Disease Everyone Should Know About, According to an Ophthalmologist
Men's Health,
It is estimated 1 out of every 12 adults in the US has Demodex blepharitis. Consider this your primer on the disease.
Mites in Your Eyelashes? FDA Approves First-Ever Treatment for Demodex Blepharitis
Everyday Health,
Blepharitis is no fun. The common inflammatory disorder typically causes red, thickened eyelids and crusty eyelashes, along…
FDA Approves Lotilaner Ophthalmic Solution for Treatment of Demodex Blepharitis
HCP Live,
US Food and Drug Administration (FDA) The US Food and Drug Administration (FDA) has approved lotilaner ophthalmology solution 0.2…
BREAKING NEWS: FDA approves XDEMVY for treatment of Demodex blepharitis
Ophthalmology Times Europe,
Demodex blepharitis impacts approximately 1 out of every 12 adults in the United States.
Paying attention to ocular surface disease preoperatively matters
Ophthalmology Times Europe,
To ensure successful surgical outcomes, clinicians need to screen for OSD and pause to prime and optimise the ocular surface.
Preoperative OSD: Targeted, efficient screening and therapies for busy practices
Ophthalmology Times,
Recent studies have shown that most patients in the cataract surgery waiting room have some form of ocular surface disease (OSD).
Understanding the Prevalence of Demodex Blepharitis in US Eye Care Clinics
AJMC,
AJMC®: Can you walk us through your published findings regarding the real-world prevalence of Demodex blepharitis?1 Why is this…